Literature DB >> 23294354

Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.

Z Li1, J Xu, P Xu, S Liu, Z Yang.   

Abstract

OBJECTIVES: Diabetic nephropathy is a major complication of diabetes and a frequent cause of end-stage renal disease and recent studies suggest that podocyte damage may play a role in the pathogenesis of this. At early onset of diabetic nephropathy there is podocyte drop-out, which is thought to provoke glomerular albuminuria and subsequent glomerular injury; however, the underlying molecular mechanisms of this remain poorly understood. Here we report that we tested the hypothesis that early diabetic podocyte injury is caused, at least in part, by up-regulation of transient receptor potential cation channel 6 (TRPC6), which is regulated by the canonical Wnt signalling pathway, in mouse podocytes.
MATERIALS AND METHODS: Mechanism of injury initiation in mouse podocytes, by high concentration of D-glucose (HG, 30 mM), was investigated by MTT, flow cytometry, real-time quantitative PCR, and western blot analysis.
RESULTS: HG induced apoptosis and reduced viability of differentiated podocytes. It caused time-dependent up-regulation of TRPC6 and activation of the canonical Wnt signalling pathway, in mouse podocytes. In these cells, blockade of the Wnt signalling pathway by dickkopf related protein 1 (Dkk1) resulted in effective reduction of TRPC6 up-regulation and amelioration of podocyte apoptosis. Furthermore, reduction of cell viability induced by HG was attenuated by treatment with Dkk1.
CONCLUSION: These findings indicate that the Wnt/β-catenin signalling pathway may potentially be active in pathogenesis of TRPC6-mediated diabetic podocyte injury.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23294354      PMCID: PMC6496492          DOI: 10.1111/cpr.12010

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  41 in total

1.  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Authors:  Tom Nijenhuis; Alexis J Sloan; Joost G J Hoenderop; Jan Flesche; Harry van Goor; Andreas D Kistler; Marinka Bakker; Rene J M Bindels; Rudolf A de Boer; Clemens C Möller; Inge Hamming; Gerjan Navis; Jack F M Wetzels; Jo H M Berden; Jochen Reiser; Christian Faul; Johan van der Vlag
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

Review 2.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

Review 3.  Wnt/beta-catenin signaling: new (and old) players and new insights.

Authors:  He Huang; Xi He
Journal:  Curr Opin Cell Biol       Date:  2008-03-12       Impact factor: 8.382

4.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

Authors:  P Mundel; J Reiser; A Zúñiga Mejía Borja; H Pavenstädt; G R Davidson; W Kriz; R Zeller
Journal:  Exp Cell Res       Date:  1997-10-10       Impact factor: 3.905

Review 5.  TRP channels: an overview.

Authors:  Stine Falsig Pedersen; Grzegorz Owsianik; Bernd Nilius
Journal:  Cell Calcium       Date:  2005 Sep-Oct       Impact factor: 6.817

6.  mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.

Authors:  Ken Inoki; Hiroyuki Mori; Junying Wang; Tsukasa Suzuki; SungKi Hong; Sei Yoshida; Simone M Blattner; Tsuneo Ikenoue; Markus A Rüegg; Michael N Hall; David J Kwiatkowski; Maria P Rastaldi; Tobias B Huber; Matthias Kretzler; Lawrence B Holzman; Roger C Wiggins; Kun-Liang Guan
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

Review 7.  Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

Authors:  Thoralf Wendt; Nozomu Tanji; Jiancheng Guo; Barry I Hudson; Angelika Bierhaus; Ravichandran Ramasamy; Bernd Arnold; Peter P Nawroth; Shi Fang Yan; Vivette D'Agati; Ann Marie Schmidt
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

8.  TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.

Authors:  Naoya Onohara; Motohiro Nishida; Ryuji Inoue; Hiroyuki Kobayashi; Hideki Sumimoto; Yoji Sato; Yasuo Mori; Taku Nagao; Hitoshi Kurose
Journal:  EMBO J       Date:  2006-11-02       Impact factor: 11.598

9.  Densin and beta-catenin form a complex and co-localize in cultured podocyte cell junctions.

Authors:  Eija Heikkilä; Mervi Ristola; Karlhans Endlich; Sanna Lehtonen; Markus Lassila; Marika Havana; Nicole Endlich; Harry Holthöfer
Journal:  Mol Cell Biochem       Date:  2007-06-21       Impact factor: 3.396

10.  Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.

Authors:  Dingkun Gui; Yongping Guo; Feng Wang; Wei Liu; Jianguo Chen; Yifang Chen; Jianhua Huang; Niansong Wang
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

View more
  24 in total

1.  High Glucose Enhances Isoflurane-Induced Neurotoxicity by Regulating TRPC-Dependent Calcium Influx.

Authors:  ZhongJie Liu; ChangQing Ma; Wei Zhao; QingGuo Zhang; Rui Xu; HongFei Zhang; HongYi Lei; ShiYuan Xu
Journal:  Neurochem Res       Date:  2017-01-06       Impact factor: 3.996

2.  Inhibition of TRPC6 channels ameliorates renal fibrosis and contributes to renal protection by soluble klotho.

Authors:  Yueh-Lin Wu; Jian Xie; Sung-Wan An; Noelynn Oliver; Nestor X Barrezueta; Mei-Hsiang Lin; Lutz Birnbaumer; Chou-Long Huang
Journal:  Kidney Int       Date:  2016-12-12       Impact factor: 10.612

3.  The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.

Authors:  Xiaoliang Zhang; Zhixia Song; Yinfeng Guo; Min Zhou
Journal:  Mol Cell Biochem       Date:  2014-10-09       Impact factor: 3.396

Review 4.  Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.

Authors:  Lili Zhou; Youhua Liu
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

Review 5.  Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.

Authors:  C Hu; L Sun; L Xiao; Y Han; X Fu; X Xiong; X Xu; Y Liu; S Yang; F Liu; Y S Kanwar
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  Yi Qi Qing Re Gao-containing serum inhibits lipopolysaccharide-induced rat mesangial cell proliferation by suppressing the Wnt pathway and TGF-β1 expression.

Authors:  Liping Yang; Xueyan Sun; Yongli Zhan; Huijie Liu; Yumin Wen; Huimin Mao; X I Dong; Ping Li
Journal:  Exp Ther Med       Date:  2016-01-28       Impact factor: 2.447

7.  MicroRNA-26a prevents endothelial cell apoptosis by directly targeting TRPC6 in the setting of atherosclerosis.

Authors:  Yong Zhang; Wei Qin; Longyin Zhang; Xianxian Wu; Ning Du; Yingying Hu; Xiaoguang Li; Nannan Shen; Dan Xiao; Haiying Zhang; Zhange Li; Yue Zhang; Huan Yang; Feng Gao; Zhimin Du; Chaoqian Xu; Baofeng Yang
Journal:  Sci Rep       Date:  2015-03-24       Impact factor: 4.379

Review 8.  Wnt/β-catenin signaling and kidney fibrosis.

Authors:  Roderick J Tan; Dong Zhou; Lili Zhou; Youhua Liu
Journal:  Kidney Int Suppl (2011)       Date:  2014-11

Review 9.  A glimpse of the pathogenetic mechanisms of Wnt/β-catenin signaling in diabetic nephropathy.

Authors:  Li Xiao; Ming Wang; Shikun Yang; Fuyou Liu; Lin Sun
Journal:  Biomed Res Int       Date:  2013-12-25       Impact factor: 3.411

10.  Mammalian target of rapamycin complex 2 signaling pathway regulates transient receptor potential cation channel 6 in podocytes.

Authors:  Fangrui Ding; Xiaoyan Zhang; Xuejuan Li; Yanqin Zhang; Baihong Li; Jie Ding
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.